Cite
HARVARD Citation
Möbus, V. et al. (2021). Phase III randomised trial comparing intense dose-dense chemotherapy to tailored dose-dense chemotherapy in high-risk early breast cancer (GAIN-2). European journal of cancer. pp. 138-148. [Online].